What is the Current Share Price of Vista Pharmaceuticals Ltd?
- Answer Field
-
Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 7.90 as on May 07 2026 02:38 PM.
As of the latest trading session, VISTA PHARMACEUTICALS LTD. is trading at ₹7.9, down by ₹-0.04 or -0.50% from its previous close. The stock has moved between ₹7.63 and ₹8.10 today. Over the past year, the stock has delivered a return of -28.66%. In the last month, it has returned 26.67%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 2.42 |
| Operating Expense | 5.79 |
| Net Profit | -2.32 |
| Net Profit Margin (%) | -95.86 |
| Earnings Per Share (EPS) | -0.41 |
| EBITDA | -2.90 |
| Effective Tax Rate (%) | 29.26 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.80 | 13.77 | 1.65 | 243.69 | 23.12 | 40.44 |
| BLISS GVS PHARMA LTD | 276.25 | 26.41 | 2.58 | 2922.42 | 105.05 | 280.20 |
| CIPLA LTD | 1309.90 | 22.25 | 3.21 | 105811.45 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 311.40 | 10.36 | 2.34 | 916.48 | 252.15 | 399.00 |
| GLAXOSMITHKLINE PHARMA LT | 2335.60 | 39.34 | 23.16 | 39566.47 | 2218.00 | 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.80 | 30.58 | 4.43 | 243.69 | 23.12 | 40.44 |
| AMRUTANJAN HEALTH CARE LTD. | 570.45 | 28.52 | 4.82 | 1649.21 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8217.20 | 98.75 | 25.71 | 20543.00 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD | 276.25 | 37.64 | 2.64 | 2922.42 | 105.05 | 280.20 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & had obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.
The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum. Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories.
The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996.
The Company's Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations are going on as per USFDA cGMP norms. The validations and stability testing studies are going on as per schedules. Its state-of-the-art Facility in India is built according to cGMP and US-FDA standards.
Vista Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 7.90 as on May 07 2026 02:38 PM.
The market cap of Vista Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 48.60 as on May 07 2026 02:38 PM.
The 52 Week High and Low of Vista Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 12.01 and ₹ 5.71.
The 1 year returns on the stock has been -24.99%.
As on May 07 2026 02:38 PM the price-to-earnings (PE) ratio for Vista Pharmaceuticals Ltd share is -6.36.
As on May 07 2026 02:38 PM, the price-to-book (PB) ratio for Vista Pharmaceuticals Ltd share is 7.25.
You can trade in Vista Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Vista Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Vista Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found